In another aspect, the present invention provides use of tirzepatide for the manufacture of a medicament for providing chronic weight management to a subject in need thereof, comprising: a) identifying a subject who has been previously treated with 15 mg of tirzepatide, or a pharmaceutically acceptable salt thereof, once weekly for a minimum of four weeks
Regarding the effect of the GLP-1 agonist, since it suppressed the expression of liver lipid synthesis genes FAS and SCD1, and consequently reduced liver triglyceride levels, its effect could be confirmed without measuring protein levels
Here are some highlights: Significant Weight Loss: Many patients experience a reduction of up to 15% of their body weight
Therefore we always recommend to use sun lotion and protection when being exposed to the sun
The Lancet, Volume 402, Issue 10403, 720730
Due to high costs and limited availability, some patients are turning to social media sites and online clinics to obtain GLP-1 receptor agonist medications